Vident Advisory, LLC Alvotech Transaction History
Vident Advisory, LLC
- $8.91 Trillion
- Q2 2025
A detailed history of Vident Advisory, LLC transactions in Alvotech stock. As of the latest transaction made, Vident Advisory, LLC holds 10,762 shares of ALVO stock, worth $97,826. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,762
Previous 25,281
57.43%
Holding current value
$97,826
Previous $244 Million
59.85%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALVO
# of Institutions
52Shares Held
16.4MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.23MShares$38.5 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$24.6 Million14.1% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.56MShares$14.2 Million0.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.39MShares$12.6 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$12 Million11.48% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.26B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...